Please try another search
ABBV faces a significant loss of revenue beginning in 2023 from Humira biosimilars For now, the company is turning in steady earnings growth Wall Street consensus outlook is bullish, but with only 3%...
Investors typically pay attention to many industry front runners during the earnings season. In early February, one of the names in the limelight was the logistics giant United Parcel Service...
Eight trading limit highs in nine days—lumber futures are literally going through the roof.The No. 1 ingredient for US house building has resumed its rally after a one-month reprieve in...
Reports FY Q4 2022 results on Thursday, Feb. 17, before the open Revenue expectation: $151.74 billion EPS expectation: $1.49 Investors have several reasons to remain excited about mega-retailer...
On Tuesday, European stocks and US futures were rising ahead of the NY session on signs that Russia-Ukraine tensions were easing. Of course, there are no guarantees the de-escalation will...
The top two cannabis companies in the world have revealed their latest earnings reports and the picture is far from encouraging.Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) and Canopy Growth (NASDAQ:CGC)...
This article was written exclusively for Investing.comCopper digesting and consolidating its move to an all-time high last May Long-term trend remains bullish Fundamentals and technicals agree FCX:...
Wall Street is debating whether the Federal Reserve might announce an emergency interest rate hike soon. Recent data released by the Labor Department shows inflation at 7.5%, the highest level in...